Written by Edgar Agents on March 12, 2018

MARCH 1 – 9

Company Form Date Issuer Counsel Underwriter Underwriter Counsel Offer $USD
XSPAND PRODUCTS LAB, INC. 1-A 03/01 Waller Lansden Dortch & Davis Alexander Capital Cozen O’Connor 10,000,000
BILIBILI INC. F-1 03/02 Skadden, Arps, Slate, Meagher & Flom BofA Merrill Lynch
J.P. Morgan Securities
Morgan Stanley & Co. International
Latham and Watkins 400,000,000
ONESMART INTERNATIONAL EDUCATION GROUP LTD F-1 03/02 Skadden, Arps, Slate, Meagher & Flom Deutsche Bank Securities Inc.
Morgan Stanley & Co. International
Simpson Thacher and Bartlett 300,000,000
HOMOLOGY MEDICINES, INC. S-1 03/02 Latham & Watkins BofA Merrill Lynch
Cowen and Company
Evercore Group
Shearman & Sterling 100,000,000
UNUM THERAPEUTICS, INC. S-1 03/02 Goodwin Procter Cowen and Company
Morgan Stanley & Co.
Ropes & Gray 86,250,000
OP BANCORP S-1 03/05 Buchalter PC Keefe, Bruyette & Woods, Inc Sheppard, Mullin, Richter and Hampton 20,000,000
VRIO CORP. S-1 03/07 Sullivan & Cromwell Citigroup Global Markets
Goldman Sachs & Co.
J.P. Morgan Securities
Morgan Stanley & Co.
Simpson Thacher & Bartlett 100,000,000

Edgar Agents is proud to help issuers, worldwide, reduce their financial risk of going public with our Locked-Cap & Success/Abort Fee Program. Click here to meet our CEO.


20 Fun Facts about RegA+! Yay! Compliance!

Investor Letter to CEOs: The Strategic Investor Initiative:

Detecting Lies on Earnings Calls

SEC Approves NYSE Rule Modifying Requirements for Hardcopy Delivery of Proxy Materials

GDPR may apply to U.S.-based companies with zero employees and no offices within the boundaries of the EU territory

SEC Suspends Trading In Three Penny Stock Companies With Ties To Cryptocurrency

M&A Corporate Buyer Beware: More Antitrust Challenges to Closed Deals

SEC Cybersecurity Disclosure and Controls Checklist

Supreme Court Limits Scope of Whistleblower Protections under Dodd-Frank: Items of Note and Potential Impacts

ISS highlights trends in shareholder proposals for the 2018 proxy season

SEC Enforcement Priorities in the Trump Era

Regulating Proxy Advisors is Anticompetitive, Counterproductive, and Possibly Unconstitutional

Top Securities Law Firms & IPOs: February 2018

Spotify’s direct listing is disruptive for an IPO. So are we.